About WeedWeek
Since 2015, WeedWeek has been the trusted source for clarity on the fast-changing cannabis industry. More than 11,000 subscribers, from top executives and investors to policymakers and advocates, rely on our incisive writing and authoritative reporting to stay informed. Our journalism has been cited by CNN, The Los Angeles Times, The San Francisco Chronicle, and Bloomberg, underscoring our reputation as an essential voice in cannabis business, policy, and culture.
WeedWeek Pro features exclusive reporting and analysis for people who make money in the world’s largest cannabis market. Pro subscribers also gain access to our private Slack community and other premium benefits designed to keep them ahead in this competitive industry.
“A lot of cannabis industry folks would be lost without their weekly dose of WeedWeek”
Editorial Ethics Policy
WeedWeek maintains a strict separation between editorial coverage and business operations. All advertising and paid content are clearly labeled to ensure readers can easily distinguish them from independent journalism. The editor has no role in business decisions, and the publisher has no role in editorial decisions.
In the event of a real or perceived conflict between WeedWeek’s editorial responsibilities and its business interests, our commitment is to transparency with our readers. WeedWeek reserves the right to refuse advertising that presents a conflict of interest, creates the appearance of one, or for any other reason. Publication of advertising does not imply endorsement of advertisers or their claims.